Webinar | January 15, 2015

Leveraging Metabolite Biomarkers For Clinical Trials

Source: Metabolon

Metabolite biomarkers can be used to establish pharmacodynamics, efficacy and safety in clinical trials and post-market surveillance studies. This 30-minute webinar will introduce a robust, highly sensitive biomarker development program that leverages a revolutionary metabolomics discovery platform to improve the range of analytes that can be measured routinely and reliably. It will also walk participants through the process of bioanalytical assay development and validation within a quality setting to support ongoing and future clinical trials.